Vinorelbine and thrombocytopenia Patient Reports February 12, 2012

Vinorelbine Side Effects Report #4745293-6
Vinorelbine side effect was reported by a Physician from GREECE on Aug 05, 2005. Female patient was diagnosed with non-small cell lung cancer and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, thrombocytopenia. Vinorelbine dosage: unknown. During the same period patient was treated with GRANULOCYTE COL, ONDANSETRON HYDROCHLORIDE, DEXAMETHASONE, DIURETIC. Patient died.

Vinorelbine Side Effects Report #4800626-7
Vinorelbine side effect was reported by a Consumer or non-health professional from FRANCE on Sept 07, 2005. Female patient was diagnosed with neoplasm malignant and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: febrile neutropenia, thrombocytopenia. Vinorelbine dosage: 20 MG/M**2; IV. Patient recovered.

Vinorelbine Side Effects Report #4800670-X
Vinorelbine side effect was reported by a Consumer or non-health professional from FRANCE on Sept 07, 2005. Female patient was diagnosed with neoplasm malignant and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: thrombocytopenia. Vinorelbine dosage: 20 MG/M**2; IV. Patient recovered.

Vinorelbine Side Effects Report #5009278-7
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, neutropenia, pain , pyrexia, thrombocytopenia. Vinorelbine dosage: 30 MG/M**2. Patient recovered.


Vinorelbine Side Effects Report #5009347-1
Vinorelbine side effect was reported by a Health Professional from UNITED STATES on May 08, 2006. Female patient was diagnosed with cervix carcinoma recurrent and was treated with Vinorelbine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, neutropenia, thrombocytopenia. Vinorelbine dosage: 30 MG/M**2. Patient recovered.